UNSPSC 51286708: Vaneprim

This classification denotes an antibiotic with the molecular formula C23H28N4O8S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M3EKF65MHG, chemically known as ( -)-alpha-(4-amino-5-(3,4,5-trimethoxybenzyl)-2-pyrimidinylamino)-3-ethoxy-4-hydroxy-alpha-toluenesulfonsaeure but more generally known as vaneprim, which bears US NIH Compound Identifier 216266. European Medicines Agency schedules Vaneprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00021MIG.

The term VANEPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, List 23). VANEPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51286708 Vaneprim, a Commodity code, covers pharmaceutical products, specifically antibiotics and opioid-antagonist medications, that state and local health agencies procure through competitive bidding and cooperative purchasing vehicles to support public health initiatives, emergency response, and disease-prevention programs. Recent solicitations show state and local governments buying antibiotics (doxycycline and ciprofloxacin) in bulk tablet form through pharmaceutical warehouse piggyback contracts, and naloxone (an opioid antagonist) paired with drug deactivation systems for community health and harm-reduction efforts. Issuing bodies include state health departments and county health authorities, which use cooperative purchasing consortiums (such as MMCAP Infuse) to aggregate demand and leverage volume pricing. These agencies manage multi-year contracts with renewal options, often including quarterly or annual delivery schedules and requiring vendors to meet drug-free workplace and E-Verify compliance standards.

Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for doxycycline hyclate and ciprofloxacin hydrochloride tablets with a 12-month initial term and two renewal years. Seminole County, Florida released an IFB in June 2026 (due July 26, 2023, per the source date) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building, funded potentially through FEMA with a two-year base contract and one-year renewal option. Recent activity concentrates in Florida and Illinois, with vendors required to handle all shipping and delivery costs and maintain required insurance coverage and employment verification compliance.